课题基金 / 基金详情

STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY

STUDIES TO EVALUATE THE POTENTIAL FOR ENVIRONMENTAL&THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
评估环境潜力的研究
批准号:
9335709
负责人:
Victor Johnson
金额:
$370.37万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-13 至 2017-08-12

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
研究4-甲基环己烯乙醇(MCHM)诱导皮肤致敏的潜力的研究已于2016财年完成并报告。皮肤暴露于纯MCHM浓度超过20%时,会对涂抹部位的皮肤产生刺激,100%浓度时产生明显毒性,但不会引起致敏。用≥75%粗MCHM处理的小鼠也表现出皮肤刺激的迹象,尽管与纯MCHM相比较弱。也有证据表明,100%粗MCHM对小鼠有明显的毒性,尽管其严重程度低于纯MCHM。真皮应用粗MCHM浓度≥5%时,引流淋巴结淋巴细胞增殖增加。与对照组相比,≥20%粗MCHM处理小鼠的刺激指数(SI)显着增加,这是一种致敏指标。这些结果表明,在无刺激性的暴露浓度下,粗MCHM有可能引起皮肤致敏。PAC混合物评估程序(PAC- map)提供了一个框架,用于评估单个多环芳烃化合物(PAC)的广度,定义PAC混合物,以及复杂的含PAC的环境样品,使用体外/短期体内测试电池,包括广泛的端点。选择性pac具有广泛的毒性(致癌性、免疫毒性、生殖和发育毒性、神经毒性)和一系列复杂的作用机制。特别是,许多PACs与体液免疫功能的抑制有关,免疫毒性已被确定为估计PACs致癌潜力的信息参数。作为预测混合效应的潜在测试电池的一部分,我们研究了单个pac调节抗原特异性抗体反应和影响骨髓细胞学的潜力。已经完成了阳性对照苯并(a)芘和效力较弱的PAC -菲的剂量反应研究,并收到了两项研究的报告草稿。另外三种化合物(芘、二苯并噻吩和苊醌)的实验室方案已获得批准,预计将于2017年第一季度完成生命期研究。对成年小鼠和大鼠在整个发育过程和成年早期暴露于地下水污染物磺环烷的潜在免疫毒性评估的生活中部分已经完成。评估暴露于饮用水污染的偏氰酸钠后免疫功能的筛选研究也已完成。这些研究的报告草案预计将于2017财年第一季度发布。在B6C3F1/N小鼠和HSD大鼠中进行的两组多壁碳纳米管吸入暴露30天后的免疫毒性研究已经完成,第三组暴露时间为90天的研究正在进行中。
英文摘要
Studies to investigate the potential for 4-Methylcyclohexanemethanol (MCHM) to induce dermal sensitization were completed and reported in FY16. Dermal exposure to pure MCHM was found to produce irritation of the skin at the application site at concentrations above 20% and overt toxicity at the 100% concentration, but did not induce sensitization. Mice treated with ≥75% crude MCHM also showed evidence of dermal irritation, although weaker when compared to pure MCHM. There was also evidence of overt toxicity in mice treated with 100% crude MCHM, although the severity was less than pure MCHM. Dermal application of crude MCHM resulted in increased lymphocyte proliferation in the draining lymph node at concentrations ≥5%. The Stimulation Index (SI), a measure of sensitization, was significantly increased in mice treated with ≥20% crude MCHM, relative to the vehicle control group. These results indicate that crude MCHM has the potential to cause dermal sensitization at exposure concentrations that are non-irritating. The PAC Mixtures Assessment Program (PAC-MAP) provides the framework for assessing a breadth of individual polycyclic aromatic compounds (PACs), defined PAC mixtures, and complex PAC-containing environmental samples using an in vitro/short-term in vivo testing battery that includes a broad spectrum of endpoints. Select PACs have been associated with a wide range of toxicities (carcinogenicity, immunotoxicity, reproductive and developmental toxicity, neurotoxicity) and a complicated array of mechanisms of action. In particular, many PACs have been associated with suppression of humoral immune function and immunotoxicity has been identified as an informative parameter for estimating the carcinogenic potential of PACs. As part of the potential testing battery to predict mixture effects, we have examined the potential for individual PACs to modulate the antigen specific antibody response and affect bone marrow cytology. Dose response studies for the positive control Benzo(a)pyrene and the less potent PAC, Phenanthrene have been completed and draft reports received for both studies. Laboratory protocols for three additional compounds, pyrene, dibenzothiophene and acenaphthenequinone, have been approved and the in life studies are expected to be completed in Q1FY17. The in-life portion of an assessment of the potential immunotoxicity oral exposure to the groundwater contaminant sulfolane has been completed in adult mice and rats exposed throughout development and early adulthood. Screening studies to assess immune function following exposure to the drinking water contaminate sodium metavanadate have also been completed. Draft reports for these studies are expected in Q1FY17. Two sets of immunotoxicity studies, conducted in B6C3F1/N mice and HSD rats following 30-day inhalation exposures to multi walled carbon nanotubes have been completed and the in life work for a third study, with an exposure duration of 90 days, is ongoing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金